当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析 - 现金流量表

千金药业

(600479)

  

流通市值:42.65亿  总市值:50.16亿
流通股本:4.19亿   总股本:4.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金898,339,610.323,668,781,157.52,753,669,163.261,755,790,068.27
  收到其他与经营活动有关的现金37,149,514.61190,753,093.32165,321,087.9584,855,239.25
  经营活动现金流入小计935,489,124.933,859,534,250.822,918,990,251.211,840,645,307.52
  购买商品、接受劳务支付的现金372,003,991.311,484,097,006.611,151,404,589.69765,441,144.73
  支付给职工以及为职工支付的现金275,878,398.43727,461,455.98561,837,345.02416,373,620.7
  支付的各项税费85,631,938.26330,145,692.36244,635,935.85197,025,380.59
  支付其他与经营活动有关的现金303,628,360.43837,585,128.5718,144,004.75506,272,231
  经营活动现金流出小计1,037,142,688.433,379,289,283.452,676,021,875.311,885,112,377.02
  经营活动产生的现金流量净额-101,653,563.5480,244,967.37242,968,375.9-44,467,069.5
二、投资活动产生的现金流量:
  收回投资收到的现金30,011,818.634,687,8792,400,0002,400,000
  取得投资收益收到的现金-4,566,896.21,513,950117,000
  处置固定资产、无形资产和其他长期资产收回的现金净额-2,218,068.19205,500205,500
  投资活动现金流入小计30,011,818.6311,472,843.394,119,4502,722,500
  购建固定资产、无形资产和其他长期资产支付的现金23,081,486.44124,167,277.1959,847,063.835,957,906.49
  投资支付的现金-818,306,060.02803,000,000390,000,000
  投资活动现金流出小计23,081,486.44942,473,337.21862,847,063.8425,957,906.49
  投资活动产生的现金流量净额6,930,332.19-931,000,493.82-858,727,613.8-423,235,406.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,000,000--
  收到其他与筹资活动有关的现金-132,522,366.255,594,632.235,594,632.23
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-134,522,366.255,594,632.235,594,632.23
  偿还债务支付的现金-7,000,0003,000,0003,000,000
  分配股利、利润或偿付利息支付的现金2,560165,449,386.97155,983,451.814,892,421.01
  其中:子公司支付给少数股东的股利、利润2,56012,770,4005,080,0004,840,000
  支付其他与筹资活动有关的现金-111,069,011.9816,585,92016,555,920
  筹资活动现金流出小计2,560283,518,398.95175,569,371.8124,448,341.01
  筹资活动产生的现金流量净额-2,560-148,996,032.7-169,974,739.58-18,853,708.78
五、现金及现金等价物净增加额-94,725,791.31-599,751,559.15-785,733,977.48-486,556,184.77
  加:期初现金及现金等价物余额736,043,191.351,335,794,750.51,335,794,750.51,335,794,750.5
  期末现金及现金等价物余额641,317,400.04736,043,191.35550,060,773.02849,238,565.73
补充资料:
  净利润-375,670,800.76-174,035,961.39
  资产减值准备-4,067,560.71-2,038,165.9
  固定资产和投资性房地产折旧-59,220,152.9-28,962,072.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,220,152.9-28,962,072.51
  无形资产摊销-19,180,623.31-7,165,553.96
  长期待摊费用摊销-16,031,528.98-8,460,032.57
  处置固定资产、无形资产和其他长期资产的损失--1,875,639.98--8,827.08
  固定资产报废损失-597,551.7-123,399.66
  公允价值变动损失--2,407,585.49--1,372,771.77
  财务费用-2,028,322.05-36,566.67
  投资损失--44,191,162.06--18,803,638.62
  递延所得税-98,211.45--2,556,479.55
  其中:递延所得税资产减少--5,918,450.21--5,912,925.48
    递延所得税负债增加-6,016,661.66-3,356,445.93
  存货的减少--8,469,772.27-44,537,350.31
  经营性应收项目的减少--180,777,765.26--361,639,594.53
  经营性应付项目的增加-244,398,674.81-52,380,038.56
  其他--35,421,767.33--
  现金的期末余额-736,043,191.35-849,238,565.73
  减:现金的期初余额-1,335,794,750.5-1,335,794,750.5
  现金及现金等价物的净增加额--599,751,559.15--486,556,184.77
公告日期2026-04-292026-04-292025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑